Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Santos da Silva Jorge
Chief Executive Officer at MoonLake Immunotherapeutics. Filing since 15 Feb 2024.
CIK 0001920509
Company
Date
Role
Action
Shares
Amount
Of holding
MLTX
MoonLake Immunotherapeutics
10 Jul 2026
Chief Executive Officer
Sold on a plan
68,289
$1.37M
2.4%
MLTX
MoonLake Immunotherapeutics
9 Jul 2026
Chief Executive Officer
Sold on a plan
33,936
$679.06K
1.2%
MLTX
MoonLake Immunotherapeutics
1 Jul 2026
Chief Executive Officer
Sold on a plan
47,775
$956.93K
1.6%
MLTX
MoonLake Immunotherapeutics
13 Apr 2026
Chief Executive Officer
Sold at will
51,873
$945.64K
1.7%
MLTX
MoonLake Immunotherapeutics
10 Apr 2026
Chief Executive Officer
Sold at will
98,127
$1.81M
3.2%
MLTX
MoonLake Immunotherapeutics
9 Dec 2025
Chief Executive Officer
Sold at will
70,000
$1.01M
2.4%
MLTX
MoonLake Immunotherapeutics
8 Dec 2025
Chief Executive Officer
Sold at will
130,000
$1.96M
4.2%
MLTX
MoonLake Immunotherapeutics
29 Feb 2024
Chief Executive Officer
Sold on a plan
4,740
$264.92K
0.2%
MLTX
MoonLake Immunotherapeutics
28 Feb 2024
Chief Executive Officer
Sold on a plan
56,065
$3.08M
1.8%
MLTX
MoonLake Immunotherapeutics
27 Feb 2024
Chief Executive Officer
Sold on a plan
62,810
$3.45M
2.0%
MLTX
MoonLake Immunotherapeutics
21 Feb 2024
Chief Executive Officer
Sold on a plan
1,125
$62.18K
0.0%
MLTX
MoonLake Immunotherapeutics
20 Feb 2024
Chief Executive Officer
Sold on a plan
20,000
$1.15M
0.6%
MLTX
MoonLake Immunotherapeutics
16 Feb 2024
Chief Executive Officer
Sold on a plan
20,000
$1.20M
0.6%
MLTX
MoonLake Immunotherapeutics
15 Feb 2024
Chief Executive Officer
Sold on a plan
20,000
$1.20M
0.6%
14 decisions on file.
